A real-life setting evaluation of the effect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary centre in Israel

OBJECTIVES: The effectiveness of remdesivir, a Food and Drug Administration-approved drug for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been repeatedly questioned during the current coronavirus disease 2019 (COVID-19) pandemic. Most of the recently reported studies were rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldberg, Elad, Ben Zvi, Haim, Sheena, Liron, Sofer, Summer, Krause, Ilan, Sklan, Ella H., Shlomai, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2021
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939997/
https://www.ncbi.nlm.nih.gov/pubmed/33705849
http://dx.doi.org/10.1016/j.cmi.2021.02.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939997/
https://www.ncbi.nlm.nih.gov/pubmed/33705849
http://dx.doi.org/10.1016/j.cmi.2021.02.029

Ejemplares similares